in Newswire May 8, 2018

Lawsuit Claims Takeda, Eli Lilly Hid Bladder Cancer Risks Associated with Diabetes Drug Actos

by Erin Gilmore

Last Updated on May 8, 2018

Fernandez v. Takeda Pharmaceuticals America, Inc. et al

Filed: May 8, 2018 § 2:18cv1142

Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company are facing a proposed class action in which the plaintiff alleges the companies attempted to cover up that their type II diabetes treatment, Actos, presented a risk of bladder cancer.

Law(s)

State(s)

California

Last Updated on May 8, 2018 — 3:05 PM

Erin Gilmore

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen. She is an honest writer, a faithful friend, and a mediocre bassist.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.